Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Risk of atrial fibrillation in big people under the magnifying glass of G. J. Mendel.

Trenkwalder T, Schunkert H.

Eur Heart J. 2019 Feb 5. doi: 10.1093/eurheartj/ehz037. [Epub ahead of print] No abstract available.

PMID:
30722015
2.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
3.

Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.

Trenkwalder T, Nelson CP, Musameh MD, Mordi IR, Kessler T, Pellegrini C, Debiec R, Rheude T, Lazovic V, Zeng L, Martinsson A, Gustav Smith J, Gådin JR, Franco-Cereceda A, Eriksson P, Nielsen JB, Graham SE, Willer CJ, Hveem K, Kastrati A, Braund PS, Palmer CNA, Aracil A, Husser O, Koenig W, Schunkert H, Lang CC, Hengstenberg C, Samani NJ.

Int J Cardiol. 2019 Feb 1;276:212-217. doi: 10.1016/j.ijcard.2018.11.094. Epub 2018 Nov 17.

PMID:
30482443
4.

The early repolarization pattern: Echocardiographic characteristics in elite athletes.

Reinhard W, Trenkwalder T, Haller B, Meindl C, Schoenfeld J, Kaess BM, Hengstenberg C, Schunkert H, Pressler A, Halle M, Scherr J.

Ann Noninvasive Electrocardiol. 2018 Nov 14:e12617. doi: 10.1111/anec.12617. [Epub ahead of print]

PMID:
30427098
5.

Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction.

Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, Mayr NP, Kasel AM, Gaede L, Blumenstein J, Kastrati A, Schunkert H, Joner M, Hilker M, Hengstenberg C, Husser O.

Clin Res Cardiol. 2018 Aug 28. doi: 10.1007/s00392-018-1364-6. [Epub ahead of print]

PMID:
30155732
6.

Multicenter Evaluation of Prosthesis Oversizing of the SAPIEN 3 Transcatheter Heart Valve. Impact on Device Failure and New Pacemaker Implantations.

Pellegrini C, Kim WK, Holzamer A, Walther T, Mayr NP, Michel J, Rheude T, Nuñez J, Kasel AM, Trenkwalder T, Kaess BM, Joner M, Kastrati A, Schunkert H, Hilker M, Möllmann H, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Jul 14. pii: S1885-5857(18)30239-1. doi: 10.1016/j.rec.2018.06.005. [Epub ahead of print] English, Spanish.

PMID:
30017841
7.

Predictors of Need for Permanent Pacemaker Implantation and Conduction Abnormalities With a Novel Self-expanding Transcatheter Heart Valve.

Pellegrini C, Husser O, Kim WK, Holzamer A, Walther T, Rheude T, Mayr NP, Trenkwalder T, Joner M, Michel J, Chaustre F, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):145-153. doi: 10.1016/j.rec.2018.01.011. Epub 2018 Mar 16. English, Spanish.

PMID:
29551701
8.

Incidental findings in multislice computed tomography prior to transcatheter aortic valve implantation: frequency, clinical relevance and outcome.

Trenkwalder T, Lahmann AL, Nowicka M, Pellegrini C, Rheude T, Mayr NP, Voss S, Bleiziffer S, Lange R, Joner M, Kasel AM, Kastrati A, Schunkert H, Husser O, Hadamitzky M, Hengstenberg C.

Int J Cardiovasc Imaging. 2018 Jun;34(6):985-992. doi: 10.1007/s10554-018-1305-5. Epub 2018 Feb 21.

PMID:
29468355
9.

Comparison of Carbohydrate Antigen 125 and N-Terminal Pro-Brain Natriuretic Peptide for Risk Prediction After Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Schmid H, Trenkwalder T, Mayr NP, Joner M, Kasel AM, Holdenrieder S, Nunez J, Sanchis J, Bodi V, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Am J Cardiol. 2018 Feb 15;121(4):461-468. doi: 10.1016/j.amjcard.2017.11.020. Epub 2017 Nov 27.

PMID:
29306485
10.

Determinants of elevated carbohydrate antigen 125 in patients with severe symptomatic aortic valve stenosis referred for transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Reinhard W, Trenkwalder T, Koenig W, Mayr NP, Joner M, Núñez J, Holdenrieder S, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Biomarkers. 2018 May;23(3):299-304. doi: 10.1080/1354750X.2018.1423706. Epub 2018 Jan 15.

PMID:
29297708
11.

Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015.

Trenkwalder T, Pellegrini C, Holzamer A, Philipp A, Rheude T, Michel J, Reinhard W, Joner M, Kasel AM, Kastrati A, Schunkert H, Endemann D, Debl K, Mayr NP, Hilker M, Hengstenberg C, Husser O.

Catheter Cardiovasc Interv. 2017 Nov 11. doi: 10.1002/ccd.27385. [Epub ahead of print]

PMID:
29130616
12.

Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.

Husser O, Kim WK, Pellegrini C, Holzamer A, Walther T, Mayr PN, Joner M, Kasel AM, Trenkwalder T, Michel J, Rheude T, Kastrati A, Schunkert H, Burgdorf C, Hilker M, Möllmann H, Hengstenberg C.

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2078-2087. doi: 10.1016/j.jcin.2017.06.026.

13.

Steerable Induction of the Thymosin β4/MRTF-A Pathway via AAV-Based Overexpression Induces Therapeutic Neovascularization.

Ziegler T, Kraus M, Husada W, Gesenhues F, Jiang Q, Pinkenburg O, Trenkwalder T, Laugwitz KL, le Noble F, Weber C, Kupatt C, Hinkel R.

Hum Gene Ther. 2017 Oct 3. doi: 10.1089/hum.2017.013. [Epub ahead of print]

PMID:
28726522
14.

Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation.

Rheude T, Pellegrini C, Michel J, Trenkwalder T, Mayr NP, Kessler T, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Int J Cardiol. 2017 Oct 1;244:93-99. doi: 10.1016/j.ijcard.2017.06.024. Epub 2017 Jun 13.

PMID:
28645804
15.

[Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].

Trenkwalder T, Kessler T, Schunkert H.

Herz. 2017 Aug;42(5):440-448. doi: 10.1007/s00059-017-4576-z. Review. German.

PMID:
28536780
16.

Ventricular and Supraventricular Ectopy in Subjects With Early Repolarization.

Trenkwalder T, King R, Kaess BM, Hengstenberg C, Schunkert H, Ittermann T, Felix SB, Busch M, Dörr M, Reinhard W.

Am J Cardiol. 2017 Jul 1;120(1):92-97. doi: 10.1016/j.amjcard.2017.03.254. Epub 2017 Apr 12.

PMID:
28495433
17.

[Practical guidelines for genetic testing in cardiovascular diseases].

Reinhard W, Trenkwalder T, Schunkert H.

Herz. 2017 Aug;42(5):485-491. doi: 10.1007/s00059-017-4571-4. Review. German.

PMID:
28484805
18.

Novel frame-shift mutation in PKP2 associated with arrhythmogenic right ventricular cardiomyopathy: a case report.

Trenkwalder T, Deisenhofer I, Hadamitzky M, Schunkert H, Reinhard W.

BMC Med Genet. 2015 Dec 23;16:117. doi: 10.1186/s12881-015-0263-1.

19.

Genetics of coronary artery disease: Short people at risk?

Trenkwalder T, Kessler T, Schunkert H, Erdmann J.

Expert Rev Cardiovasc Ther. 2015 Nov;13(11):1169-72. doi: 10.1586/14779072.2015.1094377. Epub 2015 Sep 28.

PMID:
26414801
20.

Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway.

Trenkwalder T, Deindl E, Bongiovanni D, Lee S, Schunkert H, Kupatt C, Hinkel R.

Expert Opin Biol Ther. 2015;15 Suppl 1:S175-85. doi: 10.1517/14712598.2015.1011122. Epub 2015 Feb 4.

PMID:
25652683

Supplemental Content

Loading ...
Support Center